Centessa Pharmaceuticals PLC
NASDAQ:CNTA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.73
18.67
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Centessa Pharmaceuticals PLC
Wall Street
Price Targets
CNTA Price Targets Summary
Centessa Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for
CNTA
is 29 USD
with a low forecast of 24.24 USD and a high forecast of 36.75 USD.
CNTA Last Price Targets
Centessa Pharmaceuticals PLC
The latest public price target was made on Nov 15, 2024 by
Debjit Chattopadhyay
from
Guggenheim
,
who expects
CNTA
stock to
rise by 60%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Debjit Chattopadhyay
Guggenheim
|
28
USD
Upside 60% |
1 month ago
Nov 15, 2024
|
Centessa Pharmaceuticals (CNTA) PT Raised to $28 at Guggenheim
StreetInsider
|
Jeffrey Hung
Morgan Stanley
|
26
USD
Upside 48% |
3 months ago
Sep 19, 2024
|
Centessa upgraded to Overweight from Equal Weight at Morgan Stanley
TheFly
|
Kelly Shi
Jefferies
|
19
USD
Upside 8% |
3 months ago
Sep 11, 2024
|
Centessa Pharmaceuticals (CNTA) PT Raised to $19 at Jefferies
StreetInsider
|
Kostas Biliouris
BMO Capital
|
20
USD
Upside 14% |
3 months ago
Sep 10, 2024
|
BMO Capital Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)
StreetInsider
|
|
Kostas Biliouris
BMO Capital
|
15
USD
Downside 14% |
4 months ago
Aug 14, 2024
|
BMO Capital Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CNTA's stock price target?
Price Target
29
USD
According to Wall Street analysts, the average 1-year price target for
CNTA
is 29 USD
with a low forecast of 24.24 USD and a high forecast of 36.75 USD.
You don't have any saved screeners yet
